dbACP: A Comprehensive Database of Anti-Cancer Peptides

13 result(s) have been found!

Accession Name Sequence Source/Organism Mechanism Assay Type Cell Line Cancer Type Activity
dbacp02972 GA-K3 FLGWLFKWAKK Undecapeptide analogues derived from Brevinin-1EMa Cell membrane disruption MTT/MTS assay A-498 Renal cancer IC50 : 41.21 µM
dbacp02973 GA-K3 FLGWLFKWAKK Undecapeptide analogues derived from Brevinin-1EMa Cell membrane disruption MTT/MTS assay A-549 Lung cancer IC50 : 25.20 µM
dbacp02974 GA-K3 FLGWLFKWAKK Undecapeptide analogues derived from Brevinin-1EMa Cell membrane disruption MTT/MTS assay HCT-116 Colon cancer IC50 : 27.00 µM
dbacp02975 GA-K3 FLGWLFKWAKK Undecapeptide analogues derived from Brevinin-1EMa Cell membrane disruption MTT/MTS assay MKN-45 Gastric cancer IC50 : 26.70 µM
dbacp02976 GA-K3 FLGWLFKWAKK Undecapeptide analogues derived from Brevinin-1EMa Cell membrane disruption MTT/MTS assay PC-3 Prostate cancer IC50 : 47.69 µM
dbacp02977 GA-K3 FLGWLFKWAKK Undecapeptide analogues derived from Brevinin-1EMa Cell membrane disruption MTT/MTS assay SK-MEL-2 Skin cancer IC50 : 27.39 µM
dbacp02978 GA-K3 FLGWLFKWAKK Undecapeptide analogues derived from Brevinin-1EMa Cell membrane disruption MTT/MTS assay SK-OV-3 Ovarian cancer IC50 : 27.39 µM
dbacp02979 GA-K3 FLGWLFKWAKK Brevinin-1EMa Cell membrane disruption MTT/MTS assay A-498 Renal cancer IC50 : 41.21 µM
dbacp02980 GA-K3 FLGWLFKWAKK Brevinin-1EMa Cell membrane disruption MTT/MTS assay A-549 Lung cancer IC50 : 25.20 µM
dbacp02981 GA-K3 FLGWLFKWAKK Brevinin-1EMa Cell membrane disruption MTT/MTS assay HCT-116 Colon cancer IC50 : 27.00 µM
dbacp02982 GA-K3 FLGWLFKWAKK Brevinin-1EMa Cell membrane disruption MTT/MTS assay MKN-45 Gastric cancer IC50 : 26.70 µM
dbacp02983 GA-K3 FLGWLFKWAKK Brevinin-1EMa Cell membrane disruption MTT/MTS assay PC-3 Prostate cancer IC50 : 47.69 µM
dbacp02984 GA-K3 FLGWLFKWAKK Brevinin-1EMa Cell membrane disruption MTT/MTS assay SK-MEL-2 Skin cancer IC50 : 27.39 µM